Very interesting. I previously outlined how I thought leronlimab's disruption of the mTOR pathway could act as an antiviral by stopping viral splitting. Disruption of mTOR also downregulates neuropilin-1. So now we know of 2 and possibly 3 ways leronlimab acts against the virus.